Medigen Biotechnology Corp. (TPEX:3176)

Medigen Biotechnology Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,103	4,514	6,243	4,685	7,999	8,228
Market Cap Growth	-22.09%	-27.70%	33.24%	-41.43%	-2.78%	-4.46%
Enterprise Value	5,867	6,470	8,430	7,328	10,273	10,336
Last Close Price	29.45	32.40	44.80	33.60	57.40	59.20
PS Ratio	2.52	3.29	5.39	4.44	2.04	13.37
PB Ratio	0.82	0.90	1.25	0.72	1.25	1.83
P/TBV Ratio	2.57	3.05	4.20	2.25	3.52	4.96
P/FCF Ratio	1059.00	-	-	-	21.32	-
P/OCF Ratio	79.19	119.03	-	-	15.44	-
EV/Sales Ratio	3.61	4.71	7.28	6.94	2.62	16.79
EV/EBITDA Ratio	38.11	-	-	-	10.62	-
EV/EBIT Ratio	-	-	-	-	13.17	-
EV/FCF Ratio	1514.48	-	-	-	27.38	-
Debt / Equity Ratio	0.19	0.20	0.57	0.43	0.15	0.26
Debt / EBITDA Ratio	5.82	-	-	-	1.02	-
Debt / FCF Ratio	243.56	-	-	-	2.64	-
Asset Turnover	0.25	0.18	0.13	0.12	0.55	0.11
Inventory Turnover	1.02	1.04	0.87	1.34	2.55	1.54
Quick Ratio	3.51	3.20	1.81	5.32	3.60	2.72
Current Ratio	4.43	3.96	2.05	6.40	4.62	3.24
Return on Equity (ROE)	-2.80%	-4.43%	-25.64%	-29.95%	19.60%	-23.59%
Return on Assets (ROA)	-0.10%	-1.78%	-8.33%	-11.46%	6.79%	-10.38%
Return on Capital (ROIC)	-0.11%	-1.95%	-9.01%	-12.50%	7.44%	-11.36%
Return on Capital Employed (ROCE)	-	-	-	-	10.90%	-
Earnings Yield	-1.86%	-4.54%	-8.99%	-14.42%	-0.66%	-4.11%
FCF Yield	0.09%	-0.38%	-8.68%	-27.46%	4.69%	-9.97%
Buyback Yield / Dilution	0.03%	0.03%	-0.16%	-0.11%	0.01%	-0.22%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.